Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions

Baeken Chris; Anna-Katharine Brem; Martijn Arns; Andre R Brunoni; Igor Filipčić; Ganho-Ávila Ana; Berthold Langguth; Frank Padberg; Emmanuel Poulet; Fady Rachid; Alexander T Sack; Marie-Anne Vanderhasselt; Djamila Bennabi

doi:10.1097/YCO.0000000000000533

Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions

Baeken Chris, Anna-Katharine Brem, Martijn Arns, Andre R Brunoni, Igor Filipčić, Ganho-Ávila Ana, Berthold Langguth, Frank Padberg, Emmanuel Poulet, Fady Rachid, Alexander T Sack^*, Marie-Anne Vanderhasselt, Djamila Bennabi

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Abstract

PURPOSE OF REVIEW: After three decades of clinical research on repetitive transcranial magnetic stimulation (rTMS), major depressive disorder (MDD) has proven to be the primary field of application. MDD poses a major challenge for health systems worldwide, emphasizing the need for improving clinical efficacy of existing rTMS applications and promoting the development of novel evidence-based rTMS treatment approaches.

RECENT FINDINGS: Several promising new avenues have been proposed: novel stimulation patterns, targets, and coils; combinatory treatments and maintenance; and personalization and stratification of rTMS parameters, and treatment of subpopulations.

SUMMARY: This opinion review summarizes current knowledge in the field and addresses the future direction of rTMS treatment in MDD, facilitating the establishment of this clinical intervention method as a standard treatment option and continuing to improve response and remission rates, and take the necessary steps to personalize rTMS-based treatment approaches.

Original language	English
Pages (from-to)	409–415
Number of pages	7
Journal	Current Opinion in Psychiatry
Volume	32
Issue number	5
Early online date	27 May 2019
DOIs	https://doi.org/10.1097/YCO.0000000000000533
Publication status	Published - Sep 2019

Keywords

BIPOLAR DEPRESSION
DEEP TMS
DOUBLE-BLIND
EFFICACY
MAJOR DEPRESSION
METAANALYSIS
NETWORK
RTMS
TMS TREATMENT
TREATMENT-RESISTANT DEPRESSION
depression
efficacy
repetitive transcranial magnetic stimulation

Access to Document

10.1097/YCO.0000000000000533

Cite this

Chris, B., Brem, A-K., Arns, M., Brunoni, A. R., Filipčić, I., Ana, G-Á., Langguth, B., Padberg, F., Poulet, E., Rachid, F., Sack, A. T., Vanderhasselt, M-A., & Bennabi, D. (2019). Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions. Current Opinion in Psychiatry, 32(5), 409–415. https://doi.org/10.1097/YCO.0000000000000533

@article{d0f5741f942141388deae151ed21b564,

title = "Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions",

abstract = "PURPOSE OF REVIEW: After three decades of clinical research on repetitive transcranial magnetic stimulation (rTMS), major depressive disorder (MDD) has proven to be the primary field of application. MDD poses a major challenge for health systems worldwide, emphasizing the need for improving clinical efficacy of existing rTMS applications and promoting the development of novel evidence-based rTMS treatment approaches.RECENT FINDINGS: Several promising new avenues have been proposed: novel stimulation patterns, targets, and coils; combinatory treatments and maintenance; and personalization and stratification of rTMS parameters, and treatment of subpopulations.SUMMARY: This opinion review summarizes current knowledge in the field and addresses the future direction of rTMS treatment in MDD, facilitating the establishment of this clinical intervention method as a standard treatment option and continuing to improve response and remission rates, and take the necessary steps to personalize rTMS-based treatment approaches.",

keywords = "BIPOLAR DEPRESSION, DEEP TMS, DOUBLE-BLIND, EFFICACY, MAJOR DEPRESSION, METAANALYSIS, NETWORK, RTMS, TMS TREATMENT, TREATMENT-RESISTANT DEPRESSION, depression, efficacy, repetitive transcranial magnetic stimulation",

author = "Baeken Chris and Anna-Katharine Brem and Martijn Arns and Brunoni, {Andre R} and Igor Filip{\v c}i{\'c} and Ganho-{\'A}vila Ana and Berthold Langguth and Frank Padberg and Emmanuel Poulet and Fady Rachid and Sack, {Alexander T} and Marie-Anne Vanderhasselt and Djamila Bennabi",

year = "2019",

month = sep,

doi = "10.1097/YCO.0000000000000533",

language = "English",

volume = "32",

pages = "409–415",

journal = "Current Opinion in Psychiatry",

issn = "0951-7367",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "5",

}

Chris, B, Brem, A-K, Arns, M, Brunoni, AR, Filipčić, I, Ana, G-Á, Langguth, B, Padberg, F, Poulet, E, Rachid, F, Sack, AT, Vanderhasselt, M-A & Bennabi, D 2019, 'Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions', Current Opinion in Psychiatry, vol. 32, no. 5, pp. 409–415. https://doi.org/10.1097/YCO.0000000000000533

TY - JOUR

T1 - Repetitive transcranial magnetic stimulation treatment for depressive disorders

T2 - current knowledge and future directions

AU - Chris, Baeken

AU - Brem, Anna-Katharine

AU - Arns, Martijn

AU - Brunoni, Andre R

AU - Filipčić, Igor

AU - Ana, Ganho-Ávila

AU - Langguth, Berthold

AU - Padberg, Frank

AU - Poulet, Emmanuel

AU - Rachid, Fady

AU - Sack, Alexander T

AU - Vanderhasselt, Marie-Anne

AU - Bennabi, Djamila

PY - 2019/9

Y1 - 2019/9

N2 - PURPOSE OF REVIEW: After three decades of clinical research on repetitive transcranial magnetic stimulation (rTMS), major depressive disorder (MDD) has proven to be the primary field of application. MDD poses a major challenge for health systems worldwide, emphasizing the need for improving clinical efficacy of existing rTMS applications and promoting the development of novel evidence-based rTMS treatment approaches.RECENT FINDINGS: Several promising new avenues have been proposed: novel stimulation patterns, targets, and coils; combinatory treatments and maintenance; and personalization and stratification of rTMS parameters, and treatment of subpopulations.SUMMARY: This opinion review summarizes current knowledge in the field and addresses the future direction of rTMS treatment in MDD, facilitating the establishment of this clinical intervention method as a standard treatment option and continuing to improve response and remission rates, and take the necessary steps to personalize rTMS-based treatment approaches.

AB - PURPOSE OF REVIEW: After three decades of clinical research on repetitive transcranial magnetic stimulation (rTMS), major depressive disorder (MDD) has proven to be the primary field of application. MDD poses a major challenge for health systems worldwide, emphasizing the need for improving clinical efficacy of existing rTMS applications and promoting the development of novel evidence-based rTMS treatment approaches.RECENT FINDINGS: Several promising new avenues have been proposed: novel stimulation patterns, targets, and coils; combinatory treatments and maintenance; and personalization and stratification of rTMS parameters, and treatment of subpopulations.SUMMARY: This opinion review summarizes current knowledge in the field and addresses the future direction of rTMS treatment in MDD, facilitating the establishment of this clinical intervention method as a standard treatment option and continuing to improve response and remission rates, and take the necessary steps to personalize rTMS-based treatment approaches.

KW - BIPOLAR DEPRESSION

KW - DEEP TMS

KW - DOUBLE-BLIND

KW - EFFICACY

KW - MAJOR DEPRESSION

KW - METAANALYSIS

KW - NETWORK

KW - RTMS

KW - TMS TREATMENT

KW - TREATMENT-RESISTANT DEPRESSION

KW - depression

KW - efficacy

KW - repetitive transcranial magnetic stimulation

U2 - 10.1097/YCO.0000000000000533

DO - 10.1097/YCO.0000000000000533

M3 - Review article

C2 - 31145145

VL - 32

SP - 409

EP - 415

JO - Current Opinion in Psychiatry

JF - Current Opinion in Psychiatry

SN - 0951-7367

IS - 5

ER -